Dual-Targeting OH2 Oncolytic Virus Therapy Overcomes Immune Resistance in TNBC via PD-L1/DDR1 Silencing and GM-CSF Expression
BIO Web Conf., 237 (2026) 02009
DOI: https://doi.org/10.1051/bioconf/202623702009
EDPS Account
